88047279
Jul 21, 2018
Pharmaceutical preparations for use in treatment of diseases, namely, metabolic diseases, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, cancers and tumors; pharmaceutical preparations for use in treatment of hematological, diabetic, muscular, rheumatic, immunological, respiratory, central nervous system, bone, digestive, gastrointestinal, and liver diseases; pharmaceutical preparations for use in treatment of inflammatory bowel disease (IBD), namely, Crohn's disease and ulcerative colitis (UC); pharmaceutical preparations for use in treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)
Pharmaceuticals